Примери за използване на Coadministration на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Coadministration with.
Recommendation for coadministration.
Coadministration with CYP3A4 inducers.
Recommendations concerning coadministration.
Coadministration with CYP3A4 inhibitors.
Recommendations concerning coadministration.
Therefore coadministration is not recommended.
Recommendation concerning coadministration.
Coadministration of telaprevir with Aptivus/ritonavir is not recommended.
Recommendations concerning coadministration.
Coadministration of diltiazem and atazanavir/ritonavir has not been studied.
Recommendations concerning coadministration.
Coadministration of voriconazole and sirolimus is contraindicated see section.
The net effect of coadministration is not clear.
Careful monitoring of blood glucose is recommended during coadministration.
Recommendations concerning coadministration with PREVYMIS.
Coadministration of Stalevo with non-selective monoamine oxidase(MAO-A and MAO-B).
Recommendations concerning coadministration in adults.
Coadministration of quetiapine with Victrelis is contraindicated(see section 4.3).
Recommendation concerning coadministration with ZEPATIER.
Coadministration of glecaprevir/pibrentasvir with efavirenz is not recommended.
Limited data are available for coadministration with indinavir.
Coadministration of lithium and MicardisPlus is not recommended(see section 4.4).
Glecaprevir is affected to a lower extent by coadministration with pibrentasvir.
Coadministration of fluconazole and pimozide is contraindicated(see section 4.3).
No dose adjustment is required during coadministration with strong CYP2C8 inhibitors.
Coadministration of EVOTAZ with voxilaprevir-containing regimens is not recommended.
Target animal safety can be compromised in case of inadvertent coadministration of ionophores such as monensin, salinomycin, and narasin.
Coadministration of warfarin and VIRACEPT may affect concentrations of warfarin.
Although the clinical relevance of such interactions is unknown,it is recommended that coadministration of potent ENT1, CNT3 or BCRP inhibitors be avoided during the 4- to 5-day cladribine treatment.